Survival differences according to baseline characteristics of patient with advanced heart failure treated with levosimendan
Aims: To assess whether baseline characteristics (age, New York Heart Association functional class, left ventricular ejection fraction, glomerular filtration rate, systolic blood pressure, and N-terminal pro-brain natriuretic peptide) predicted different survival functions in patients with advanced...
Saved in:
| Main Authors: | Angel-Alberto Garcia-Peña, Alejandro Mariño, Oscar-Mauricio Muñoz-Velandia, Daniela Saa-González |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-07-01
|
| Series: | SAGE Open Medicine |
| Online Access: | https://doi.org/10.1177/20503121251357357 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LEVOSIMENDAN IN PREOPERATION THERAPY FOR CARDIOSURGERY IN PATIENTS WITH CHRONIC HEART FAILURE
by: M. A. Babaev, et al.
Published: (2017-03-01) -
Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of Levosimendan
by: Piergiuseppe Agostoni, et al.
Published: (2019-11-01) -
The Use of Levosimendan for the Treatment of Heart Failure and its Potential Organoprotective Effects
by: N. B. Lebedeva, et al.
Published: (2022-05-01) -
IMPACT OF LEVOSIMENDAN ON RENAL FUNCTION IN COMPLEX TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE
by: M. V. Lediakhova, et al.
Published: (2018-05-01) -
Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children
by: Prijić Sergej, et al.
Published: (2011-01-01)